The Pharma & Healthcare Comms & Reputation Conference Programme
26th November 2024 | Central London
08.15 Registration, Informal Networking & GIC Opening Remarks
09.00 Morning Co-Chairs’ Opening Remarks
Iris Buttinoni, Communications Director Merck Italy, Merck Group
Fiona Cohen, Head Of Corporate Reputation For Europe, Teva Pharmaceuticals
REPUTATION, TRUST & PERCEPTION
09.10 Navigate The Choppy Waters Of Public Perception & Craft Meaningful Stories That Instil Trust, Enhance Reputation & Dispel Misinformation
- How are you traversing the complex UK pharma and healthcare environment? Utilise your expertise and PR stratagem to build stories that are creative and compelling, whilst remaining compliant
- Decode the dynamics of public perception, identify reputation risks and unlock opportunities for ultimate brand enhancement
- Navigate sensitive topics with grace and care, with new tactics for conveying emotionally charged messages with regulation at the forefront
- Trust reimagined – chart a course through the post-Covid misinformation landscape and explore strategies for rebuilding trust in an era of uncertainty
Jill Pearcy, Director, Reputation, ABPI
Katrin Sulzmann, Senior Vice President Corporate Communications, Fresenius Kabi
Elisa Agate, Director, Oncology Communications (EUCAN), AstraZeneca
Andrew Escott, Head Of Corporate Affairs For The EU Cluster, Senior Director, Bristol Myers Squibb
PRACTICAL AI & AUTOMATION IN COMMS
New for 2024!
09.40 Empowering Pharma & Healthcare With AI Strategies That Bridge Innovation & Human Connection For Impactful Communication & Improved Reputation
- The tech revolution: explore the evolving terrain of AI adoption, embracing brand new opportunities and overcoming challenges and barriers along the way to keep ahead of the curve
- Deploy integrated and seamless AI solutions which are GDPR compliant for secure and personalised content
- Infusing AI with a human essence: future-proof your pharma communication strategies with a touch of innovation and empathy that reinforce your brand’s personal touch
- Uncover the full suite of AI’s capabilities for your organisation, and ensure that its use is making a practical and tangible impact on the business
10.00 Bonus Session; Reserved For Exclusive Conference Partner
10.30 Morning Refreshment Break With Informal Networking
PUBLIC TRUST IN PHARMA
Double Perspective!
11.00 Navigate The Choppy Waters Of Public Perception & Craft Meaningful Stories That Instil Trust, Enhance Reputation & Dispel Misinformation
- How are you traversing the complex UK pharma and healthcare environment? Utilise your expertise and PR stratagem to build stories that are creative and compelling, whilst remaining compliant
- Decode the dynamics of public perception, identify reputation risks and unlock opportunities for ultimate brand enhancement
- Navigate sensitive topics with grace and care, with new tactics for conveying emotionally charged messages with regulation at the forefront
- Trust reimagined – chart a course through the post-Covid misinformation landscape and explore strategies for rebuilding trust in an era of uncertainty
11.00 Anna-Lisa Fisher, Pillar Lead, Medical Communications, Boehringer Ingelheim
11.20 Stefaan Fiers, Head Of Corporate Communication, Public Affairs & Patient Advocacy, Takeda
PUBLIC HEALTH & IMMUNISATION
11.40 Effectively Dealing With Concerns Surrounding Public Wellbeing With Strategies That Strengthen The Health Improvement Agenda & Fight The Politicisation Of Vaccines
- Utilising lessons learnt from public campaigns to inform and design comms strategies that resonate with the public and address preventative healthcare topics
- Navigating vaccines: mitigate the risks of vaccine hesitancy through clear, transparent and trust-increasing comms campaigns which correct misinformation, inspire confidence and increase uptake
- From rare diseases to brand-new medications: how can we clearly communicate the complexity of the pharmaceutical landscape and market access timelines to the general public – while remaining compliant
James Fitzpatrick, Senior Global Director, Corporate & External Affairs, CSL Seqirus
SUSTAINABILITY, SOCIAL IMPACT & VALUE IN HEALTHCARE
12.00 Unleash The Power Of Healthcare Communication By Promoting Sustainability, Social Impact & Value To Drive Commercial Success In Tomorrow’s Industry Landscape
- How can you integrate sustainability into your communication strategies effectively, and advocate for environmentally friendly practices in healthcare messaging
- Greenwashing vs. real and authentic action: unearth new strategies to ensure you are following through and delivering on your promises to secure customer trust
- Explore best practices in upholding ethical standards in healthcare comms, ensuring transparency and equity in information access to best support patients and HCPs
- Measure the impact of healthcare communications and evaluate the effectiveness of messaging on sustainability, social impact and value, and how you can stand out from other industries in regard to ESG goals and targets
- Enhance social impact by collaborating with communities and stakeholders to drive positive change through communication initiatives
Chiara Montecuocco, Strategic Communications Project Lead, UCB
THE SOCIAL MEDIA COMMS EVOLUTION
12.20 Is Pharma Making The Most Of Social Media? Navigating Risks, Harnessing Innovation & Cultivating Trust In Pharma’s Evolving Social Media Landscape
- Increase your reach! Craft compelling, accessible and relevant social media content to engage new demographics around healthcare
- TikTok temptations! Are you embracing the risk or missing out on new opportunities and platforms? Explore the untapped potential of TikTok in pharma communications to build communities, disseminate educational materials and build trust in healthcare
- Navigate boundaries and strike the right balance between bold innovation and regulatory compliance in the digital space to showcase the new era of pharma communication
- Clinicians, industry, or influencers? Redefine social media leadership for pharma and embrace a multi-stakeholder approach to enhance reputation and awareness
Magdalena Manevska, Director, Head Of Social Media Communications, Philips
Avril Fudge, Senior Director PR & Comms EMENA, Accord Healthcare
John Wahba, Senior Director & Global Medical Education Lead, Gilead Sciences
Chiara Montecuocco, Strategic Communications Project Lead, UCB
12.50 Lunch & Informal Networking For Speakers, Delegates & Partners
INFORMAL BREAKOUT DISCUSSIONS
A) Crisis
Ilda Sabanovic, Lead Public Affairs & Market Access Biogen Austria, Biogen
B) Greenwashing
Stephen Cull, Obesity Communications, International Lead, Novo Nordisk
C) Fair Market Value
D) Misinformation
13.50 Afternoon Co-Chairs’ Opening Remarks
Koeyli Jaluka, Head Of Communication – Northwestern Europe & Canada, Roche
Marina Moustaka, Director, International Medical Communications Ad Promo, Allergan Aesthetics, An AbbVie Company
GOVERNMENT RELATIONS, REGULATORY COMPLIANCE & POLICY SPOTLIGHT
14.00 With Changes Looming Across The Board, Navigate Choppy Political Landscapes & Policy Shifts For Sustainable Pharma Engagement In The UK & Europe
- Navigate political transitions with new strategies for building and maintaining fruitful relationships with new governments amidst political shifts in the UK and Europe
- Measuring success in a new era: rethink metrics and explore the implications of governmental shifts towards health and wellbeing economy on pharma’s success evaluation
- Understand the real impact of the newly proposed European legislation and how to best factor this into your strategies and protect your brand reputation
- It works both ways! Deep dive into how you can utilise your communications to help influence and shape how government partners work with the industry
Lisa Timothy, External Affairs Director UK & Ireland, Takeda
Mark Grossien, Head of Strategic Communications, Sandoz
Ilda Sabanovic, Lead Public Affairs & Market Access Biogen Austria, Biogen
ADVANCING DIGITAL COMMS
14.30 Digital Dynamics: Build Strong Foundations For The Future Of Pharma Communications With Visual Storytelling, Tech Innovation & Resilience To Crisis At The Heart
- Digital first? How have digital and new technologies changed the pharma comms landscape – and how can you build constant adjustments into your strategies
- Discover how automation and new technologies in pharma communication has evolved, and how you can leverage tools that safeguard and amplify your brand
- Utilise the potential of video as a dynamic and underutilised communication tool in pharma engagement strategies to widen your technological toolkit
DATA ANALYTICS & IMPACT MEASUREMENT
14.50 Quantify Your Comms Performance & Drive Innovations Which Elevate Your Strategies With Effective Data & Analytics Approaches Which Measure Impact & Influence Success
- Metrics mastery which showcases the tangible business impact and reputation boost of your comms strategies and informs ongoing plans for stronger stakeholder connections
- Ignite innovation amidst budgetary boundaries and ensure you are crafting a compelling case for the value proposition that gets stakeholders excited
- How can you transform health data into gold by navigating the ethical and commercial landscape to design effective comms strategies?
15.10 Bonus Session; Reserved For Exclusive Conference Partner
15.40 Afternoon Refreshment Break With Informal Networking
PATIENT ENGAGEMENT
16.10 Power To The Patients! How Can Pharma Comms Strategies Elevate Patient Engagement, To Develop Collaborative Relationships, Build Trust & Provide Meaningful Support
- Dial in on the everyday dialogue: how can pharma and life sciences initiate daily conversations that guide and support patients, nurturing a mutually beneficial and trusted partnership?
- Increase your reach across demographics! Address barriers to engagement and amplify marginalised voices to ensure inclusion at every level of the pharma-patient relationship
- Are you ensuring patient advocacy group partnerships are accurately informing comms strategies for digestible and useful patient support material?
- Balance online interactions by striking the right tone and managing delicate online interactions to address concerns, without escalating negative sentiment
Marta Garcia Manrique, R&D, Chief Patient Officer, Servier
Dr. Sujan Sivasubramaniyam, Head Of Medical Affairs & Patient Advocacy, UK & Ireland, CSL Behring
Chiara Travagin, Global Communications Manager, Chiesi Group
ENGAGING STAKEHOLDERS
16.40 Boost Strategic Engagement By Cultivating Trust, Confidence & Relevance In Pharma-Stakeholder Relationships
- Harness new platforms and channels to showcase corporate values and build confidence and trust in the organisation amongst external stakeholders
- One voice: how can you build one coherent voice and messaging plan as a basis for engaging, multi-stakeholder communications?
- Navigate compliance with new and informed strategies for engaging digital communications within regulatory boundaries to sustain stakeholder relationships
- Craft communication strategies that demonstrate pharma’s commitment to societal relevance and sustainable growth to anticipate stakeholders and secure buy-in
INTERNAL COMMUNICATIONS & BUY-IN
17.00 Unlock The Power Of Internal Communications & Employee Advocacy To Navigate Complexity, Cultivate Connectivity & Build Positive Company Cultures & Pride
- Fostering internal connectivity: break down silos and encourage communication across department lines with strategies for effective engagement without traditional means
- Build a company identity that fosters employee pride and buy-in by cultivating a transparent, inclusive culture from top to bottom
- How can you produce company-wide campaigns across diverse markets and regulatory landscapes while managing different language and cultural barriers?
Marco Gerometta, Communications Director – Global Clinical Operations, R&D, GSK
Kristian Lysgaard, Vice President, Corporate Communications, Orifarm
17.40 Afternoon Co-Chairs’ Closing Remarks & Official Close Of Conference
